Department of Imaging NHS Forth Valley, Larbert, UK.
Department of Imaging NHS Greater Glasgow and Clyde, Glasgow, UK.
Br J Radiol. 2022 May 1;95(1133):20211241. doi: 10.1259/bjr.20211241. Epub 2022 Feb 24.
OBJECTIVES: The purpose of this article is to review the technical and radiological aspects of MagSeed localisation, to assess its accuracy based on post-localisation mammograms and excision specimen X-rays and to discuss the radiological experience of our institutions. METHODS: Two-year data were collected retrospectively from three NHS boards from the West of Scotland. A total of 309 MagSeeds were inserted under mammographic or ultrasonographic guidance in 300 women with unifocal, multifocal and/or bilateral breast lesions at the day of surgery or up to 30 days prior to it. Radiological review of post-localisation mammograms and intraoperative specimen X-rays as well as a review of the surgical outcomes were performed to assess the accuracy and efficacy of the method. Our experience relating to the technique's strengths and downsides were also noted. RESULTS: The MagSeeds were inserted on average 7.2 days before surgery. The localisation technique was straight forward for the radiologists. In 99% of the cases, the MagSeed was successfully deployed and 100% of the successfully localised lesions were excised at surgery. There was no difference in the accuracy of the localisation whether this was mammographically or ultrasonographically guided. On post-localisation mammograms, the MagSeed was radiologically accurately positioned in 97.3% of the cases. No delayed MagSeed migration was observed. On the specimen X-rays, the lesion was centrally positioned in 45.1%, eccentric within more than 1 mm from the margin in 35.7% and in 14.8% it was at the specimen's margin. The re-excision rate was 18.3%. CONCLUSION: The MagSeed is an accurate and reliable localisation method in breast conserving surgery with good surgical outcomes. ADVANCES IN KNOWLEDGE: To our knowledge, the radiological aspects of MagSeed localisation have not been widely described in peer-reviewed journals thus far.
目的:本文旨在回顾 MagSeed 定位的技术和影像学方面,根据定位后的乳房 X 光片和切除标本 X 光片评估其准确性,并讨论我们机构的放射学经验。
方法:从苏格兰西部的三个 NHS 委员会回顾性收集了两年的数据。在手术当天或之前 30 天内,共有 300 名患有单发、多发和/或双侧乳房病变的女性在乳房 X 线或超声引导下共插入 309 个 MagSeed。对定位后的乳房 X 光片和术中标本 X 光片进行影像学复查,并对手术结果进行复查,以评估该方法的准确性和有效性。我们还注意到与该技术优缺点相关的经验。
结果:MagSeed 平均在手术前 7.2 天插入。放射科医生对定位技术的操作简单。在 99%的情况下,MagSeed 成功部署,100%的成功定位病变在手术中被切除。无论采用乳房 X 线还是超声引导,定位的准确性均无差异。在定位后的乳房 X 光片中,MagSeed 在 97.3%的情况下放射学上定位准确。未观察到延迟的 MagSeed 迁移。在标本 X 光片中,病变中心位于 45.1%,偏心距离超过 1 毫米的边缘 35.7%,位于标本边缘的 14.8%。再次切除率为 18.3%。
结论:MagSeed 是保乳手术中一种准确可靠的定位方法,具有良好的手术效果。
知识进展:据我们所知,MagSeed 定位的放射学方面迄今为止尚未在同行评议的期刊上广泛描述。
Breast Care (Basel). 2021-8
Eur J Nucl Med Mol Imaging. 2024-8
Breast Cancer Res Treat. 2020-8
AJR Am J Roentgenol. 2018-8-7
Breast Cancer Res Treat. 2018-2-16
AJR Am J Roentgenol. 2018-2-15